/explore
|
You are here 
|
drmalcolmkendrick.org | ||
| | | | |
www.wired.com
The first vaccine candidate entered human trials five days after the pandemic was declared. Behind the scenes at Moderna and an unprecedented global sprint. |
|
| | | | | ||
| | | | |
changingtimes.media
This article has been updated. Latest update 29/3/2021 Audio digest (before updates): French translation (before updates) @ France Soir. Researchers say there's evidence within the SARS-CoV-2 spike protein that suggests the virus is a product of genetic manipulation. Exiled Chinese scientist Li-Meng Yan says SARS-CoV-2 is an "unrestricted bioweapon" and there's been "large-scale, organised scientific... |
|
| | | | | ||
| | | | |
nateserg808.wixsite.com
An alleged outbreak of disease in Wuhan, China in late December 2019 was quickly reported as having developed into an 'epidemic' and on the 11th March 2020 the WHO declared it to be a 'pandemic'.( - I might have a total of 4 words of my own in here - thank you to the dedicated investigators - )In quick succession, countries around the world were being 'locked down' in an apparent effort to contain the disease; the phrase 'flatten the curve' was used to suggest that the numbers of cases were |
|
| | | | | ||
| | | | |
www.nature.com
Timely evaluation of the protective effects of Coronavirus Disease 2019 (COVID-19) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern is urgently needed to inform pandemic control planning. Based on 78 vaccine efficacy or effectiveness (VE) data from 49 studies and 1,984,241 SARS-CoV-2 sequences collected from 31 regions, we analyzed the relationship between genetic distance (GD) of circulating viruses against the vaccine strain and VE against symptomatic in... |
|
| | | |||
